Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-10

Clinical Trial Update: Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial of a modified-process Hib/Hep B vaccine in infants has completed, with results posted in July 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hib/Hep B vaccine (modified process)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Haemophilus Influenzae Type B, Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2009-07-10